Energy & environment · 03/01/2018Updated: 10/17/2026 · 1 min read
FDA Seeks Partial Site Release for New Building at Winchester Engineering and Analytical Center
Summary
The U.S. Nuclear Regulatory Commission has approved a license amendment application from the FDA to use radioactive byproduct material for research and development at the Winchester Engineering and Analytical Center in Massachusetts, allowing the FDA to proceed with construction of a new 3-story building.
Original source language: Federal Register — Nuclear Regulatory CommissionOpen original release →